As shown in Figure 4A, positive p53 protein expression was correlated with poorer PFS in a subgroup of patients diagnosed with lymph node metastasis (N+) before initial treatment (p=0.032). This evidence concerns the gene TP53 and metastatic malignant neoplasm in the lymph nodes.